E-DRUG Archives (by date)

• Thread Index

February 28, 2003
• [e-drug] WHO and training (cont'd)
  • From: Susan Foster <sfoster@bu.edu>
February 27, 2003
• [e-drug] Drugs with narrow therapeutic index
  • From: "Cimf" <cimf@colfarma.org.ar>
• [e-drug] Revolving Drug Funds (cont)
  • From: "Owino, Wasunna" <WOwino@policy.or.ke>
• [e-drug] Re: ICH guidelines (cont)
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] WHO & Training (cont)
  • From: "Geeta Pradeep" <geeta_pradeep@hotmail.com>
• [e-drug] Revolving Drug Fund Sudan
  • From: richardl@bu.edu
• [e-drug] WHO and training (cont)
  • From: JBRusso@aol.com
• [e-drug] WHO and training (cont)
  • From: msesay@unicef.org
• [e-drug] WHO Indicators (cont)
  • From: ahmed ayesha <aisha_ahmed_pk@yahoo.com>
February 26, 2003
• [e-drug] Direct to Consumer Advertising
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] WHO Indicators
  • From: "Eurek Ranjit" <dhyan@wlink.com.np>
• [e-drug] Origins of AIDS transmission (cont'd)
  • From: "Carolyn Green" <greencm@dial.pipex.com>
• [e-drug] WHO and training (cont)
  • From: richardl@bu.edu
• [e-drug] WHO and training (cont)
  • From: "Perla Mordujovich" <pmordujo@atlas.med.unlp.edu.ar>
February 25, 2003
• [e-drug] WHO and training
  • From: hollowayk@who.in
• [e-drug] Origins of AIDS (cont'd)
  • From: Hilbrand Haak <haakh@chd-consultants.nl>
February 22, 2003
• [e-drug] WHO EML Committee agenda 31 march - 3 April 2003 (cont)
  • From: grayr@who.int
• [e-drug] WHO position vacant
  • From: Guitelle Baghdadi <baghdadig@who.ch>
• [e-drug] Origins of AIDS (cont)
  • From: Beverley Snell <bev@burnet.ed.au>
• [e-drug] Counterfeit drugs? contact WHO
  • From: e-drug@healthnet.org
• [e-drug] Short course on ARV therapy
  • From: Lut Lynen <llynen@itg.be>
February 21, 2003
• [e-drug] Origins of AIDS and inappropriate use of injections
  • From: Hilbrand Haak <haakh@chd-consultants.nl>
February 19, 2003
• [e-drug] Training for the Developing World: Can't WHO help? (cont)
  • From: ragol@who.int
• [e-drug] Training for the Developing World: Can't WHO help?
  • From: Kibumba George <kibumba@yahoo.com>
• [e-drug] WHO EDL Committee agenda 31 march - 3 April 2003 (cont)
  • From: stein@lyftingsmo.no
• [e-drug] Understanding TRIPS (Patents & Access to Drugs)
  • From: e-drug@healthnet.org
February 18, 2003
• [e-drug] RUD course (French): change of date & venue
  • From: hollowayk@who.int
• [e-drug] WHO Expert Committee on the Selection and Use of Essential
  • From: grayr@who.int
• [e-drug] WHO EDL Committee agenda 31 march - 3 April 2003
  • From: e-drug@healthnet.org
• [e-drug] Roche finally lowers price of nelfinavir
  • From: mpalmedo@cptech.org
February 16, 2003
• [e-drug] ICH guidelines (cont)
  • From: "Kirsten Myhr" <kirsten.myhr@relis.ulleval.no>
February 15, 2003
• [e-drug] Lancet: A positive result for AIDS
  • From: e-drug@healthnet.org
February 13, 2003
• [e-drug] Sell-out at WTO on Doha declaration?
  • From: ingrid.cox@geneva.msf.org
• [e-drug] 2nd Asian Course on Problem-Based Pharmacotherapy Teaching
  • From: Kathleen Holloway <hollowayk@who.int>
February 12, 2003
• [e-drug] Internet access still a nightmare in Africa
  • From: "A. Odutola" <chpss_abo@yahoo.com>
• [e-drug] Research paper on hidden drug costs (cont)
  • From: owner-e-drug@healthnet.org
• [e-drug] MSF open letter to S. African govt for a national treatment plan
  • From: "Marta Darder" <martad@xsinet.co.za>
• [e-drug] Therapeutics Letter 46: Menopausal Combined Hormone Therapy Update
  • From: "Ciprian Jauca" <jauca@ti.ubc.ca>
• [e-drug] Research paper on hidden drug costs
  • From: Hilbrand Haak <haakh@chd-consultants.nl>
• [e-drug] Can human rights serve as a tool for equality? Work in progress
  • From: richardl@bu.edu
February 11, 2003
• [e-drug] Community revolving drug schemes
  • From: Vera Lucia Luiza <vera@ensp.fiocruz.br>
• [e-drug] Study: revolving drug funds
  • From: "Gamal Khalafalla Mohammed" <gamalkh@hotmail.com>
February 10, 2003
• [e-drug] Donating books and journals to less developed countries
  • From: e-drug@usa.healthnet.org
February 09, 2003
• [e-drug] new Global Fund approvals list
  • From: e-drug@usa.healthnet.org
• [e-drug] Use of cell phones for TB compliance
  • From: "Dr. David Green" <david@on-cue.co.za>
• [e-drug] Rational Drug Management course in International Health
  • From: "Dr. Reinhard Huss" <reinhard.huss@urz.uni-heidelberg.de>
• [e-drug] ICH and women
  • From: WilbertBannenberg@compuserve.com
February 08, 2003
• [e-drug] Open letter to the WTO from Médecins sans Frontières
  • From: ellen.t.hoen@paris.msf.org
• [e-drug] WHO publication on ICH
  • From: WilbertBannenberg@compuserve.com
• [e-drug] The impact of applicability of ICH guidelines in developing
  • From: abenfeddoul@hotmail.com
• [e-drug] Letter to the Delegates to the WTO
  • From: "Philippe Swennen" <philippe.swennen@aim-mutual.org>
February 07, 2003
• [e-drug] Police bust heads in Korea today over Glivic drug protest
  • From: James Love <james.love@cptech.org>
• [e-drug] MSF Letter to the Editor in NYT re: meningitis vaccine
  • From: "Rachel COHEN" <Rachel.COHEN@newyork.msf.org>
February 05, 2003
• [e-drug] Research paper available(cont)
  • From: Libby Levison <libby@theplateau.com>
February 04, 2003
• [e-drug] E-learning Course on Health Outcomes and the Poor
  • From: Jo Hindriks <jhindriks@worldbank.org>
• [e-drug] CPTech filing in South Africa competition commission case
  • From: James Love <james.love@cptech.org>
February 03, 2003
• [e-drug] Restored sensitivity to older antibacterials?
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
• [e-drug] Research paper available: the hidden costs of procuring essential medicines
  • From: Libby Levison <libby@theplateau.com>
• [e-drug] Better access to information
  • From: Valeria Frighi <valeria.frighi@dtu.ox.ac.uk>
• [e-drug] Thalidomide's Nationwide Usage (cont)
  • From: "Vanda Zidoniene" <VandaZidoniene@VVKT.LT>
• [e-drug] Second ICIUM Conference, Thailand, 2004
  • From: John Chalker <jchalker@msh.org>